基于风险的肺癌筛查在临床实践中的应用
研究在四个州的多中心肺癌筛查项目中,纳入符合USPSTF2013标准或PLCOm2012风险≥1.34%的患者,比较仅符合某一标准及不同风险水平者的肺癌检出率。结果显示多数患者同时符合两标准,仅符合PLCOm2012标准者肺癌发生率更高,且筛查发现的非小细胞肺癌多为I-II期,良性病变手术比例较低。
要点
- 84%的患者同时符合USPSTF2013和PLCOm2012标准。
- 仅符合PLCOm2012标准者肺癌发生率为3.6/1000人年,仅符合USPSTF2013标准者为0/1000人年。
- 筛查发现的非小细胞肺癌中74%为I期或II期,因筛查行侵入性干预者占4.3%。
核心结论
- 多数患者同时符合USPSTF2013和PLCOm2012筛查标准。
- 仅符合PLCOm2012标准而不符合USPSTF2013标准者肺癌发生率更高。
- 肺癌患病率和发生率随PLCOm2012预期风险升高而增加。
- 因筛查行侵入性操作及良性病变切除的比例相对较低。
研究设计与样本
- 采用转诊队列设计,在四个州实施多中心肺癌筛查项目。
- 纳入符合USPSTF2013标准或PLCOm2012风险≥1.34%的患者。
- 回顾性提取侵入性操作数据。
- 共筛查2471例患者,其中114例诊断为肺癌。
主要发现
- 全部患者中84%同时符合两项标准,确诊肺癌患者中91%同时符合两项标准。
- 预期风险最高的10%队列肺癌患病率是最低风险10%的7倍以上。
- 仅符合PLCOm2012标准者肺癌发生率为3.6/1000人年,仅符合USPSTF2013标准者为0/1000人年。
- 筛查发现的非小细胞肺癌中74%为I期或II期。
- 3例(4.5%)手术切除针对筛查发现的良性结节,106例(4.3%)因筛查接受侵入性干预。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Current U.S. lung cancer screening guidelines use only age and smoking history; however, individual risk calculators may better stratify risk. METHODS: In a referred cohort design, we implemented a multisite lung cancer screening program across four states. We screened patients who qualified by either the USPSTF2013 criteria or a PLCOm2012 risk of greater than or equal to 1.34%. Invasive procedures were abstracted retrospectively. We compared the incidence and prevalence of lung cancer among patients who qualified by only USPSTF2013 or PLCOm2012 and along the continuum of prospective lung cancer risk using PLCOm2012. RESULTS: Of 2471 screened patients, 114 had lung cancer. Furthermore, 84% of all patients and 91% of patients who were diagnosed with having cancer qualified by both criteria. Prevalence of lung cancers were over 7 times higher in the 10% of the cohort with the highest prospective risk than the lowest risk 10%. Incidence of cancers were higher among patients who qualified only by PLCOm2012 (3.6 per 1000 person-years) compared with patients who qualified only by USPSTF2013 (0 per 1000 person-years). Of screen-detected NSCLC, 74% was stage I or II. Three (4.5%) surgical resections were performed for screen-identified nodules which proved to be benign. Overall, 106 patients (4.3%) underwent an invasive intervention due to screening. CONCLUSIONS: Most patients qualified for lung cancer screening by both UPSTSF2013 and PLCOm2012 criteria. Incidence cancers were higher among patients who qualified by PLCOm2012 but not USPSTF2013 criteria. Prevalence and incidence cancer identification increased with prospective risk. Invasive procedures and resections for benign disease were relatively low.
引用
- Rode MM, Sykes AG, Allen MS, et al. Risk-Based Lung Cancer Screening in Clinical Practice. J Thorac Oncol. 2025. PMID: 40379047. doi:10.1016/j.jtho.2025.05.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。